RAPPORT THERAPEUTICS INC (RAPP) Stock Analyst Ratings
USA - NASDAQ:RAPP - US75383L1026 - Common Stock
26.14 USD
-0.51 (-1.91%)
ChartMill assigns a Buy % Consensus number of 84% to RAPP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 52.75. This target is 101.79% above the current price.
RAPP was analyzed by 14 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about RAPP.
In the previous month the buy percentage consensus was at a similar level.
RAPP was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-16 | Truist Securities | Initiate | Buy |
| 2025-09-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-06 | HC Wainwright & Co. | Initiate | Buy |
| 2025-07-08 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-08 | JMP Securities | Initiate | Market Outperform |
| 2024-10-18 | Jones Trading | Initiate | Buy |
| 2024-07-02 | TD Cowen | Initiate | Buy |
| 2024-07-02 | Stifel | Initiate | Buy |
| 2024-07-02 | Jefferies | Initiate | Buy |
RAPPORT THERAPEUTICS INC / RAPP FAQ
Can you provide the average price target for RAPPORT THERAPEUTICS INC stock?
14 analysts have analysed RAPP and the average price target is 52.75 USD. This implies a price increase of 101.79% is expected in the next year compared to the current price of 26.14.
What is the consensus rating for RAPPORT THERAPEUTICS INC (RAPP) stock?
The consensus rating for RAPPORT THERAPEUTICS INC (RAPP) is 84.2857 / 100 . This indicates that analysts generally have a positive outlook on the stock.